User banner image
User avatar
  • admin

Posts

LUCKIN COFFEE CELEBRATES EARTH DAY IN COLLABORATION WITH OATLY

Luckin Coffee has also unveiled three new drinks using OATLY’s Barista Oat Drink as part of this collaboration. SINGAPORE, April 11, 2025 /PRNewswire/ — Luckin...

Paranovus Entertainment Technology Limited Received Nasdaq Notification Letter Related to Late Filing of Form 6-K Reporting Interim Financial Information

NEW YORK, April 11, 2025 /PRNewswire/ — Paranovus Entertainment Technology Limited (“PAVS” or the “Company”), (NASDAQ: PAVS) announced today that it has received a letter from...

Health In Tech Announces Appointment of Sanjay Shrestha to Board of Directors

STUART, Fla., April 11, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce...

Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share

BOSTON, April 11, 2025 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Partners, LLC sent a letter on April 8, 2025, to Sinovac’s...

Laboratory Services Cooperative Notifies Individuals of Security Incident

SEATTLE, April 11, 2025 /PRNewswire/ — Laboratory Services Cooperative (LSC), a non-profit organization based in Seattle, Washington, is encouraging individuals to take precautionary measures to...

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in...

Avalyn to Participate in Upcoming Investor Conference in April

CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of...

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) ROCKVILLE,...

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing...

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer

Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), a leader in...